切换至 "中华医学电子期刊资源库"

中华诊断学电子杂志 ›› 2017, Vol. 05 ›› Issue (02) : 124 -127. doi: 10.3877/cma.j.issn.2095-655X.2017.02.012

所属专题: 文献

临床研究

原发性甲状腺弥漫性大B淋巴细胞瘤的诊断学特征
冯强1, 王文洋1, 卜凡1, 李毅1,()   
  1. 1. 271000 泰安市中心医院检验科
  • 收稿日期:2017-04-04 出版日期:2017-05-26
  • 通信作者: 李毅
  • 基金资助:
    山东省医药卫生科技发展计划(2016WS0600)

Diagnostic features of primary thyroid lymphoma with diffuse large B lymphocyte

Qiang Feng1, Wenyang Wang1, Fan Bu1, Yi Li1,()   

  1. 1. Department of Clinical Laboratory, Central Hospital of Taian City, Taian 271000, China
  • Received:2017-04-04 Published:2017-05-26
  • Corresponding author: Yi Li
  • About author:
    Corresponding author: Li Yi
引用本文:

冯强, 王文洋, 卜凡, 李毅. 原发性甲状腺弥漫性大B淋巴细胞瘤的诊断学特征[J]. 中华诊断学电子杂志, 2017, 05(02): 124-127.

Qiang Feng, Wenyang Wang, Fan Bu, Yi Li. Diagnostic features of primary thyroid lymphoma with diffuse large B lymphocyte[J]. Chinese Journal of Diagnostics(Electronic Edition), 2017, 05(02): 124-127.

目的

探讨原发性甲状腺弥漫性大B淋巴细胞瘤(DLBCL)的诊断学特征。

方法

回顾性分析1例原发性甲状腺DLBCL临床资料,并复习相关文献。

结果

患者甲状腺左叶可触及直径约6 cm的结节,甲状腺球蛋白抗体阳性,铁蛋白372 ng/ml,甲状腺激素检查均正常;彩超结果:左侧颈部及右侧锁骨上淋巴结显示;CT结果:右肺门及纵隔内多发淋巴结肿大并钙化。病理学显示左侧甲状腺DBCLB-生发中心来源(Ⅱ期A组);免疫组化:白细胞分化抗原20(CD20)、B细胞特异性激活蛋白(PAX-5)、CD10、B细胞淋巴瘤6(BCL-6)、BCL-2、多发性骨髓瘤癌基因-1(MUM-1)、原癌基因c-myc均阳性,CD3、CD5均T细胞阳性,CD30、间变性淋巴瘤激酶(ALK)均阴性,增生指数67(Ki67)约85%。骨髓活检及骨髓病理显示:CD10偶见阳性、CD20散在少量阳性、CD5偶见阳性、CD38偶见阳性、MUM-1阴性、BCL-6阴性、细胞周期蛋白D1(CyclinD1)阴性、Ki67定位差。流式结果未检测到明显免疫表型异常的淋巴细胞。

结论

原发于甲状腺的弥漫性大B淋巴细胞瘤是少见淋巴瘤之一,依据常规病理免疫组化,结合B超等影像学检测手段对其进行准确诊断,是选择合理有效治疗方案的重要依据。

Objective

To investigate the diagnostic features and treatment of primary thyroid lymphoma with diffuse large B lymphocyte (DLCBL).

Methods

One patient of primary thyroid lymphoma with diffuse large B lymphocyte was diagnosed.The related literatures were reviewed.

Results

A nodule with diameter of 6 cm could be touched in the left lobe of thyroid with the patient.Thymoglobulin antibody was positive, and the levels of other thyroid hormones were normal.The level of Ferritin was 372 ng/ml.The lymph nodes were detected on the left neck and right supraclavicular with ultrasound.Multiple lymph nodes enlargement and calcification were found in the right hilum and mediastinum.DLCBL(Stage ⅡA) in the left thyroid originated from germinal center with pathological examination.Cluster of differentiation 20(CD20), B cell specific active protein-5(PAX-5), CD10, B cell lymphoma-6 gene(BCL-6), B cell lymphoma-2 gene (BCL-2), Multiple myeloma oncogene-1 (MUM-1), c-myc were positive by immunohistochemistry.Meanwhile, bone marrow biopsy and bone marrow pathology showed, CD3, CD5 were positive in T lymphocytes.CD30, anaplastic lymphoma kinase (ALK) were negative.Ki 67 was about 85%.CD10, CD20, CD5, CD38 were occasionally positive.MUM-1, BCL-6, CyclinD1 were negative.Ki 67 was not clearly located.The immunophenotype of lymphocytes were normal with flow cytometry.

Conclusions

Diffuse large B cell lymphoma located in thyroid is one of the rare lymphomas.An optional protocol is based on precision diagnosis according to pathological characteristics and other imageological examinations.

图1 原发性甲状腺恶性淋巴瘤患者左侧甲状腺组织病理检查结果。a图示免疫组化染色CD20呈棕褐色,强阳性(HE ×400);b图示免疫组化染色PAX-5呈黄色,阳性(HE ×400);d图示甲状腺DLBCL,细胞比正常淋巴细胞增大,有的可见核仁,为生发中心来源(HE ×400);c图示甲状腺DLBCL的大体结构低倍镜观察(HE ×40);DLBCL为弥漫性大B细胞淋巴瘤
[1]
Derringer GA,Thompson LD,Frommelt RA, et al. Malignant lymphoma of the thyroid gland:a clinicopathologic study of 108 cases[J]. Am J Surg Pathol, 2000, 24(5): 623-639.
[2]
张焕虎,苏超,周海蒙, 等.102例甲状腺微小乳头状癌的诊治分析[J]. 中国肿瘤临床, 2012, 39(1): 49-51.
[3]
张云,杨丽娟,母义明, 等. 原发性甲状腺淋巴瘤临床特征分析[J]. 中国病案, 2015, 16(3): 86-87.
[4]
蔡建珊,孙强,殷保兵. 原发性甲状腺淋巴瘤的诊断和治疗进展[J]. 上海医药, 2016, 37(6): 3-6.
[5]
Chai YJ,Hong JH,Koo do H, et al.Clinicopathological characteristics and treatment outcomes of 38 cases of primary thyroid lymphoma:a multicenter study[J]. Ann Surg Treat Res, 2015, 89(6): 295-299.
[6]
Graft-Baker A,Sosa JA,Roman SA.Primary thyroid lymphoma:a review of recent developments in diagnosis and histology-driven treatment[J]. Curr Opin oncol, 2010, 22(1): 17-22.
[7]
陈燕,肖立,朱雄增, 等. 弥漫性大B细胞淋巴瘤的免疫学分型与预后的关系[J]. 中华病理学杂志, 2014, 43(6): 383-388.
[8]
夏宇,戴晴,姜玉新, 等. 原发甲状腺淋巴瘤的超声表现[J]. 中华超声影像学杂志, 2010, 19(2): 131-133
[9]
刘隽颖,王勇,邹霜梅, 等. 原发甲状腺淋巴瘤的超声诊断与病理对照研究[J]. 国际医学放射学杂志, 2017, 40(1): 23-27.
[10]
宋飞艳,程蕾蕾,陈永乐, 等. 实时三维超声心动图评价淋巴瘤患者蒽环类药物化疗后左心室亚临床功能的价值[J/CD]. 中华诊断学电子杂志, 2015, 3(3): 155-158.
[11]
Hwang YC,Kim TY,Kim WB, et al.Clinical characteristics of primary thyroid lymphoma in Koreans[J]. Endocr J, 2009, 56(3): 399-405.
[12]
许士田,叶关毅. 原发性甲状腺淋巴瘤一例并文献复习[J]. 浙江临床医学, 2016, 18(4): 726-727.
[13]
杨志寅. 现代医学科学发展中的缺憾与思考[J/CD]. 中华诊断学电子杂志2013, 1(1): 1-7.
[14]
南润玲,尚培中,张伟, 等. 原发性甲状腺淋巴瘤二例分析并文献复习[J]. 中国全科医学, 2017, 20(6): 748-750.
[15]
Motta G,Cea M,Carbone F, et al.Current standards and future Strategies in immunochemotherapy of non-Hodgkin's lymphoma[J]. J BUON, 2011, 16(1): 9-15.
[16]
Yamashita H,Nakagawa K,Asari T, et al.Radiotherapy for 41 patients with stages I and II MALT lymphoma:a retrospective study[J]. Radiother Oncol, 2008, 87(3): 412-417.
[17]
高建英,党娜,程楠, 等.99Tc-甲氧异腈显像在鼻部原发NK/T细胞淋巴瘤中的诊断价值[J/CD]. 中华诊断学电子杂志, 2016, 4(1): 59-62.
[18]
Colombat P,Brousse N,Salles G, et al.Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma:survival analyses with 7-year follow-up[J]. Ann Oncol, 2012, 23(9): 2380-2385.
[19]
陈连香,韩艳秋,王威, 等. 氟达拉滨联合异环磷酰胺治疗利妥昔单抗治疗后复发难治非霍奇金淋巴瘤21例[J]. 白血病·淋巴瘤, 2017, 26(1): 46-48.
[20]
王蕾,孙明玲,刘颖, 等. 非霍奇金淋巴瘤CHOP方案失败后用利妥昔单抗联合化疗的临床效果研究[J]. 肿瘤学杂志, 2016, 22(2): 158-160.
[1] 李永浩, 高雪菲, 郭田田, 张进, 张彩针, 刘静. 肥胖合并甲状腺癌相关机制的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(04): 311-315.
[2] 杨体飞, 杨传虎, 陆振如. 改良无充气经腋窝入路全腔镜下甲状腺手术对喉返神经功能的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 74-77.
[3] 陈航, 闵翔. 日间甲状腺切除术后出血的12例临床分析及应对措施[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 600-602.
[4] 罗佳, 赵晶晶, 曹小珍, 钟玲, 范林军, 曾令娟. 单侧腋窝双侧乳晕入路机器人甲状腺术后局部加压预防皮下隧道出血的对照研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 603-606.
[5] 黄崇植, 肖映胜, 杨熙鸿, 林炘. 甲状腺下动脉的上行分支在甲状腺术中定位喉返神经的应用研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 607-610.
[6] 袁育韬, 邢金琳, 谢克飞, 殷凯. CT征象及BRAFV600E基因突变与甲状腺乳头状癌中央区淋巴结转移的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 611-614.
[7] 崔占斌, 乔军利, 张丽丽, 韩明强. 尿碘水平与甲状腺乳头状癌患者术后复发危险度分层的相关性[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 615-618.
[8] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[9] 徐成, 王璐璐, 王少华. 洗脱液甲状腺球蛋白在甲状腺乳头状癌转移淋巴结中的应用[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 701-704.
[10] 樊丽超, 郭瑾瑛, 陈鑫. 野生型RET与RET/PTC融合基因检测对甲状腺乳头状癌中央区淋巴结清扫的指导意义[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 631-635.
[11] 黄汇, 朱信强. 131I治疗45岁以下分化型甲状腺癌的疗效及影响因素[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 627-630.
[12] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[13] 汪毅, 许思哲, 任章霞. 胸乳入路腔镜单侧甲状腺叶切除术与开放手术对分化型甲状腺癌患者术后恢复的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 542-545.
[14] 张蓉, 秦洪真, 杨晓冬, 刘爽, 刘明锋, 曹秀堂. 分化型甲状腺癌术后康复锻炼的临床应用研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 439-442.
[15] 陈大六, 宋勇罡, 赵海剑, 张晓雨. 三种不同手术入路的腔镜甲状腺癌根治术临床效果评价[J]. 中华普外科手术学杂志(电子版), 2023, 17(02): 188-191.
阅读次数
全文


摘要